Neoleukin Therapeutics (NLTX) Stock Chart & Stock Price History $23.31 -0.41 (-1.73%) (As of 12/9/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends Neoleukin Therapeutics Stock Price Performance 5 Day Performance+4.34%1 Month Performance-65.83%3 Month Performance-33.40%6 Month Performance-38.46%Year-To-Date Performance+20.28%1 Year Performance+64.39% Receive NLTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] NLTX Stock Chart for Monday, December, 9, 2024 NLTX Chart by TradingView Neoleukin Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/06/2024$22.02$21.99-0.14%$22.59$21.44246,149 shs$206.66 million12/05/2024$22.34$22.02-1.43%$22.25$20.82494,449 shs$206.94 million12/04/2024$24.57$22.34-9.08%$24.39$22.03519,047 shs$209.95 million12/03/2024$25.43$24.57-3.38%$25.93$24.49555,084 shs$230.91 million12/02/2024$25.43$25.43$26.75$24.78318,069 shs$238.99 million11/29/2024$25.80$25.43-1.43%$26.75$24.78317,555 shs$238.99 million Get the Latest News and Ratings for NLTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/28/2024$26.87$25.80-3.98%$27.68$24.60530,879 shs$242.47 million11/27/2024$22.32$26.87+20.41%$27.61$24.231.33 million shs$252.52 million11/26/2024$20.30$22.32+9.93%$22.57$20.501.30 million shs$209.72 million11/25/2024$20.30$20.30$20.93$15.481.06 million shs$190.78 million11/22/2024$15.33$20.30+32.42%$20.93$15.481.06 million shs$190.78 million11/21/2024$17.23$15.33-11.03%$17.45$15.28802,176 shs$144.07 million11/20/2024$19.82$17.23-13.07%$20.99$17.011.23 million shs$161.93 million11/19/2024$3.49$19.82+467.91%$23.79$18.942.00 million shs$186.27 million11/18/2024$34.52$3.49-89.89%$3.59$3.42113,100 shs$32.80 million11/15/2024$39.20$39.20$43.24$38.97610,721 shs$368.40 million11/14/2024$40.00$39.20-2.00%$43.24$38.97610,658 shs$368.40 million11/13/2024$71.53$40.00-44.08%$49.37$35.601.99 million shs$375.92 million11/12/2024$68.21$71.53+4.87%$74.49$69.49425,376 shs$672.24 million11/11/2024$68.21$68.21$71.60$66.60180,962 shs$641.04 million11/08/2024$69.50$68.21-1.86%$71.60$66.60180,961 shs$641.04 million Related Companies Replimune Group Stock Price Chart Pliant Therapeutics Stock Price Chart Poseida Therapeutics Stock Price Chart Autolus Therapeutics Stock Price Chart Erasca Stock Price Chart Immunome Stock Price Chart Kura Oncology Stock Price Chart Evolus Stock Price Chart Rapport Therapeutics Stock Price Chart Prothena Stock Price Chart Receive NLTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NLTX) was last updated on 12/9/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWaveBot: The Automated Trading Tool for This Bull MarketThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredFinancial Prophecy The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neoleukin Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neoleukin Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.